Riskpilot← Back to searchSign inGet full accessOVE LUNDMARK ANESTESI AB
ABActiveOrg 5566188065Ektorpsvägen 3 1trGeneral medical practice activities · NACE 8621Est. 20011 employees
Revenue 2025
SEK 0
EBITDA margin
—
-99% vs 2024
Equity ratio
94.5%
Financial strength
Net profit 2025
SEK 468K
+2569% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -26K | -99% |
| Net profit | SEK 468K | +2569% |
| Total assets | SEK 622K | +66% |
| Equity | SEK 588K | +64% |
| Employees | 1 | — |
Legal name
OVE LUNDMARK ANESTESI AB
Org number
5566188065
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
20 november 2001
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva verksamhet genom att erbjuda läkartjänster, sjukvårdstjänster och friskvård samt idka därmed förenlig verksamhet. Bolaget ska även bedriva friskvård inom EU.
Address
Ektorpsvägen 3 1tr
Phone
+46707567835
Email
ove@nackakarate.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 499 | 1 609 | 256 | 0 | 0 |
| Staff expenses | — | — | −160 | −0 | −17 |
| EBITDA | 122 | 406 | −118 | −13 | −26 |
| Depreciation & amort. | −50 | −0 | — | — | — |
| EBIT | 72 | 406 | −118 | −13 | −26 |
| Net financials | −13 | 49 | 22 | 31 | 494 |
| Profit before tax | 60 | 454 | −96 | 18 | 468 |
| Tax | −7 | −85 | — | — | — |
| Net profit | 53 | 369 | −96 | 18 | 468 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 518 | 1 417 | 716 | 375 | 622 |
| Equity | 1 467 | 1 337 | 691 | 359 | 588 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 50 | 80 | 25 | 16 | 34 |
| Total debt | 50 | 80 | 25 | 16 | 34 |
EBITDA margin
-2634000.0%
This company
15.8%
Market median
-16670986% vs market
20212025
Equity ratio
94.5%
This company
38.2%
Market median
+147% vs market
20212025
Return on equity
79.6%
This company
18.4%
Market median
+333% vs market
20212025
Net profit margin
46755300.0%
This company
8.1%
Market median
+577225826% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
OD Audit | Audit | 2020 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OVE LUNDMARK ANESTESI AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ole Deurell | Audit | 0 companies |
| Lars Ove Lundmark | Board of Directors | 0 companies |
| Bessie Marlene Salas Lundmark | Deputy Board Member | 0 companies |
| Bo Arvid Lundmark | Deputy Board Member | 0 companies |